Cargando…
Structural modification of antineoplastic drug carmofur designed to the inhibition of SARS-CoV-2 main protease: A theoretical investigation
A coherent account of the reaction mechanistic details, structural modifications, and inhibition potentials of antineoplastic drug carmofur and its modified analogs to inhibition of SARS-CoV-2 main protease (M(pro)) is reported. The survey is performed by integrating the density functional based tig...
Autores principales: | Hemati, Niloofar, Hadidi, Saba, Shiri, Farshad, Farzaei, Mohammad Hosein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656244/ https://www.ncbi.nlm.nih.gov/pubmed/34904062 http://dx.doi.org/10.1016/j.rechem.2021.100259 |
Ejemplares similares
-
Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib,
and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease
Inhibitors
por: Ma, Chunlong, et al.
Publicado: (2020) -
Ebselen, disulfiram, carmofur, PX-12, tideglusib, and shikonin are non-specific promiscuous SARS-CoV-2 main protease inhibitors
por: Ma, Chunlong, et al.
Publicado: (2020) -
1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) increases Carmofur stability and in vitro antiproliferative effect
por: Domracheva, Ilona, et al.
Publicado: (2015) -
Acridone Alkaloids: In-Silico Investigation Against SARS-CoV-2 Main Protease
por: Oderinlo, Ogunyemi Olajide, et al.
Publicado: (2022) -
Activation and maturation of SARS-CoV main protease
por: Xia, Bin, et al.
Publicado: (2011)